HAWLER Maternity Hospital Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2008
NCT00797693
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Maternity Teaching Hospital

Active Ingredients

Drugs in Phase 1 Trials (1)

bemiparin (Ivor) (1 trial)

Drugs in Other Trials (1)

misoprostol (cytotec) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stillbirth (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2